Table 1. Significance analysis examining quadruplicate binding measurements of SIINFEKL fragments.
| Peptide | p-value < | Relative binding mean (σ) |
| EKL | 0.9 | - |
| FEKL | 0.5 | - |
| FEK | 1 | - |
| NFEKL | 1 | - |
| NFEK | 0.9 | - |
| NFE | 0.9 | - |
| INFEKL | 0.001 | 7% (2%) |
| INFEK | 0.4 | - |
| INFE | 1 | - |
| INF | 0.7 | - |
| IINFEKL | 0.001 | 22% (1%) |
| IINFEK | 0.8 | - |
| IINFE | 0.9 | - |
| IINF | 0.9 | - |
| IIN | 0.5 | - |
| SIINFEK | 0.001 | 5% (1%) |
| SIINFE | 0.001 | 4% (0%) |
| SIINF | 0.001 | 8% (3%) |
| SIIN | 0.9 | - |
| SII | 0.9 | - |
| SIINFEKL | 0.001 | 100% (1%) |
| NoLigand | 0.5 | - |
The null hypothesis for the Welch-test [28] considers the distribution of respective peptide fragments measurements to not be greater than the distribution of NoLigand measurements.